AP2007004250A0 - Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia - Google Patents

Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia

Info

Publication number
AP2007004250A0
AP2007004250A0 AP2007004250A AP2007004250A AP2007004250A0 AP 2007004250 A0 AP2007004250 A0 AP 2007004250A0 AP 2007004250 A AP2007004250 A AP 2007004250A AP 2007004250 A AP2007004250 A AP 2007004250A AP 2007004250 A0 AP2007004250 A0 AP 2007004250A0
Authority
AP
ARIPO
Prior art keywords
treatment
production
monoclonal antibody
lymphocytic leukemia
chronic lymphocytic
Prior art date
Application number
AP2007004250A
Other languages
English (en)
Inventor
Villoo Morawala Patell
Original Assignee
Avestha Gengraine Tech Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avestha Gengraine Tech Pvt Ltd filed Critical Avestha Gengraine Tech Pvt Ltd
Publication of AP2007004250A0 publication Critical patent/AP2007004250A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AP2007004250A 2005-05-24 2006-05-24 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia AP2007004250A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN625CH2005 2005-05-24
PCT/IB2006/001356 WO2006126068A2 (en) 2005-05-24 2006-05-24 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia

Publications (1)

Publication Number Publication Date
AP2007004250A0 true AP2007004250A0 (en) 2007-12-31

Family

ID=37452410

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004250A AP2007004250A0 (en) 2005-05-24 2006-05-24 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia

Country Status (14)

Country Link
US (1) US20090220520A1 (xx)
EP (1) EP1883653A2 (xx)
JP (1) JP2009504136A (xx)
KR (1) KR20080039843A (xx)
CN (1) CN101238150A (xx)
AP (1) AP2007004250A0 (xx)
AU (1) AU2006250887A1 (xx)
BR (1) BRPI0610304A2 (xx)
CA (1) CA2609480A1 (xx)
IL (1) IL187400A0 (xx)
MX (1) MX2007014672A (xx)
RU (1) RU2007147414A (xx)
WO (1) WO2006126068A2 (xx)
ZA (1) ZA200711007B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101687920B (zh) 2007-06-29 2013-06-19 弗·哈夫曼-拉罗切有限公司 导致免疫球蛋白生产改善的重链突变体
CN101619305B (zh) * 2007-10-19 2013-03-20 协和干细胞基因工程有限公司 抗人cd52单克隆抗体杂交瘤细胞系、单克隆抗体、工程抗体、载体、试剂盒及其用途
CA2939492C (en) 2009-05-13 2019-03-19 Genzyme Corporation Anti-human cd52 immunoglobulins
JP2013520999A (ja) * 2010-03-04 2013-06-10 ベット・セラピューティクス・インコーポレイテッド Ｃｄ５２に対するモノクローナル抗体
US9616120B2 (en) 2010-03-04 2017-04-11 Vet Therapeutics, Inc. Monoclonal antibodies directed to CD20
GB201109238D0 (en) * 2011-06-01 2011-07-13 Antitope Ltd Antibodies
WO2013181568A2 (en) * 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to alemtuzumab
EP2856159A4 (en) 2012-06-01 2016-04-13 Momenta Pharmaceuticals Inc METHODS RELATING TO DENOSUMAB
US9828609B2 (en) 2013-03-12 2017-11-28 International Park Of Creativity Biological devices and methods for increasing the production of lycopene from plants
AR095199A1 (es) 2013-03-15 2015-09-30 Genzyme Corp Anticuerpos anti-cd52
CN106018814B (zh) * 2016-08-07 2017-11-14 深圳市南海生物科技有限公司 一种用于白血病和自身免疫病检测用试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020282D0 (en) * 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation

Also Published As

Publication number Publication date
IL187400A0 (en) 2008-02-09
RU2007147414A (ru) 2009-07-10
JP2009504136A (ja) 2009-02-05
US20090220520A1 (en) 2009-09-03
CA2609480A1 (en) 2006-11-30
AU2006250887A1 (en) 2006-11-30
MX2007014672A (es) 2008-04-08
CN101238150A (zh) 2008-08-06
WO2006126068A2 (en) 2006-11-30
EP1883653A2 (en) 2008-02-06
KR20080039843A (ko) 2008-05-07
ZA200711007B (en) 2008-11-26
WO2006126068A3 (en) 2007-08-23
BRPI0610304A2 (pt) 2010-06-08

Similar Documents

Publication Publication Date Title
IL187400A0 (en) Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia
AP2007004252A0 (en) A method for the production of a monoclonal antibody to cd20 for the treatment of B-cell lymphoma
IL191217A (en) Anti-17 mantle monoclonal antibody
IL176745A0 (en) A process for the purification of antibodies
DK2824183T3 (da) Fremgangsmåde til fremstilling af bispecifikke antistoffer
ZA200702926B (en) Monoclonal antibodies to progastrin
EP2097104A4 (en) NOVEL MONOCLONAL ANTI-GLOBULOMERIC A-BETA ANTIBODIES FOR CONFORMER A-BETA
DK3461875T3 (da) Fremgangsmåde til fremstillling af en kulbrintekomponent
DK1741768T4 (da) Fremgangsmåde til fremstilling af dieselcarbonhydrider
EP2083017A4 (en) ANTIBODIES HAVING INCREASED ADCC ACTIVITY AND METHOD FOR PRODUCING THE SAME
IL197823A0 (en) Methods for improving antibody production
SI2628746T1 (sl) Proces za koncentriranje polipeptida
EP1860120A4 (en) PROCESS FOR AN IMPROVED ANTIBODY
PL2004880T3 (pl) Sposób wytwarzania elektrody diamentowej
IL240122B (en) A method for producing an antibody
EP1956032A4 (en) MONOCLONAL ANTIBODY AGAINST CD166 AND METHOD OF MAKING SAME
FI20055666L (fi) Prosessi hiilivetykomponentin valmistamiseksi
EP1955989A4 (en) PROCESS FOR PRODUCING LOWER OLEFIN
EP2221384A4 (en) METHOD FOR MANUFACTURING ANTIBODY
EP1799252A4 (en) ANTIBODY PRODUCTION PROCESS
DE602005017574D1 (de) Verfahren zur Produktion von rekombinanten polyklonalen Immunglobulinen